Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Copenhagen Stock Exchange  >  Novo Nordisk A/S    NOVO.B   DK0060534915

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Copenhagen Stock Exchange
04/25/2016 04/26/2016 04/27/2016 04/28/2016 04/29/2016 Date
371.5 362 362.9 371 362.9 Last
2479721 2670606 1897511 3755807 4012404 Volume
-1.38% -2.56% +0.25% +2.23% -2.18% Change
Financials ( DKK)
Sales 2016 115 962 M
EBIT 2016 50 348 M
Net income 2016 39 077 M
Finance 2016 14 769 M
Yield 2016 1,99%
Sales 2017 124 719 M
EBIT 2017 54 510 M
Net income 2017 43 256 M
Finance 2017 21 235 M
Yield 2017 2,23%
P/E ratio 2016 23,52
P/E ratio 2017 20,90
EV / Sales 2016 6,17x
EV / Sales 2017 5,69x
Capitalization 730 359 M
More Financials
Company
Novo Nordisk AS engages in the research, development, manufacture, and marketing of pharmaceutical products.It operates through the Diabetes and Obesity Care; and Biopharmaceuticals segments.The Diabetes and Obesity Care segment covers insulins, glucagon-like-peptide 1, other protein-related... 
Sector
Pharmaceuticals
Calendar
04/29Earnings Release
More about the company
Surperformance© ratings of Novo Nordisk A/S
Trading Rating : Investor Rating :
More Ratings
Latest news on NOVO NORDISK A/S
04/29 NOVO NORDISK A/S : Semaglutide significantly reduces the risk of major adverse c..
04/29 NOVO NORDISK A/S : Speakers for exploring new treatment options for diabetes
04/29DJNOVO NORDISK A/S : Trims Guidance on Currency Rates
04/29 NOVO NORDISK A/S : increased adjusted operating profit by 10% in local currencie..
04/28 NOVO NORDISK A/S : Marks World Hemophilia Day by Raising Awareness of Bleeding D..
04/28 NOVO NORDISK A/S : Study Data from Novo Nordisk Provide New Insights into Peptid..
04/28 NOVO NORDISK A/S : Researchers from Novo Nordisk Report Recent Findings in Struc..
04/28 NOVO NORDISK A/S : Share repurchase programme
More news
Sector news : Pharmaceuticals - NEC
08:49aDJSequoia Reopens To New Clients -- WSJ
08:49aDJValeant Default Fears 'Cured' -- WSJ
04:58a ST JUDE MEDICAL : Abbott is counting on growth turnaround at St. Jude Medical
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
04/29 Novo Nordisk Q1 top line up 8%; EPS up 23%; CF Ops up 82%
04/29 Novo Nordisk reports Q1 results
04/28 Novo's long-acting GLP-1 analogue lowers risk of CV events in sixth and last ..
04/24 Tracking Ken Fisher's Fisher Asset Management Portfolio - Q1 2016 Update
04/22 Stock To Gift A Newborn


Comments 
Advertisement
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO.B | DK0060534915 | 4-Traders
Full-screen chart
Technical analysis trends NOVO NORDISK A/S
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions